Skip to main content
. 2018 Spring;17(2):801–810.

Table 2.

Differences between baseline and the 30th and 120th days of SGRQ scores and its components in the study groups.

SGRQ component By day 30
By day120
Placebo Vitamin D p-value Placebo Vitamin D p-value
Symptom score 10.71 ± 6.44 15.18 ± 8.85 0.050 12.26 ± 7.81 19.45 ± 8.94 0.001*
Activity score 1.88 ± 3.73 4.11 ± 3.43 0.008* 2.69 ± 3.96 8.11 ± 6.13 0.001*
Impact score 2.61 ± 3.20 3.77 ± 3.82 0.40 2.13 ± 4.39 5.76 ± 4.62 0.007*
Total score 3.73 ± 1.84 5.69 ± 2.13 0.0003* 3.99 ± 2.19 8.66 ± 3.32 0.0001*
*

Significant improvement in vitamin D group versus placebo (p < 0.05)